{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:04:55Z","timestamp":1788440695646,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002327","name":"Kela","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004037","name":"Juho Vainion S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018836","name":"Alzheimer's Research and Prevention Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018836","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Health Initiative Joint Undertaking","award":["101132933"],"award-info":[{"award-number":["101132933"]}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Center for Innovative Medicine (CIMED) at Karolinska Institutet"},{"name":"Stiftelsen Stockholms Sjukshem"},{"name":"Stockholm ALF"},{"DOI":"10.13039\/501100006636","name":"FORTE","doi-asserted-by":"crossref","award":["2023-01125"],"award-info":[{"award-number":["2023-01125"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NordForsk NJ-FINGERS grant"},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010114","name":"Yrj\u00f6 Jahnssonin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010114","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Research Funding of Oulu City Hospital and Kuopio University Hospital"},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to investigate the use of antihypertensive, lipid-lowering, antithrombotic, and glucose-lowering medication among the FINGER (Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) population during a 9-year follow-up. Also, the effects of the FINGER intervention on and differences between sexes and age groups in medication use were studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Medication data for FINGER participants were retrieved from a national register annually, starting from the study baseline. FINGER was a two-year randomized controlled trial for older adults (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091259) at risk of cognitive impairment, who were randomly allocated to a multidomain lifestyle intervention or a control group. The intervention aimed at enhancing healthy lifestyle and to manage and monitor cardiovascular and metabolic risk factors. Generalized Estimation Equations were used to assess longitudinal changes in medication use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cardiovascular and glucose-lowering medication use was common and increased over time among FINGER participants. The prevalences of medication use did not differ between the intervention and control groups. The use of cardiovascular and glucose-lowering medication was fairly similar between men and women. Older participants used more cardiovascular medication compared to younger participants throughout the follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The increasing use of cardiovascular and glucose-lowering medication in this older population at risk of cognitive impairment reflects increasing cardiovascular and diabetes morbidity, management of these risks and diseases through medication, and possible changes in medical practices. Before drawing further conclusions about the effect of the intervention on medication use, its effect on treatment adjustments should be studied. Trial registration: ClinicalTrials.gov, NCT01041989, retrospectively registered 04\/01\/2010.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s41999-025-01354-1","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:35:53Z","timestamp":1764779753000},"page":"961-973","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular and glucose-lowering medication use among older adults: results from 9-year follow-up of the FINGER trial"],"prefix":"10.1007","volume":"17","clinical-trial-number":[{"clinical-trial-number":"nct01041989","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3206-9128","authenticated-orcid":false,"given":"Maria","family":"S\u00e4\u00e4skilahti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Aarnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esko","family":"Lev\u00e4lahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Lehtisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Kivipelto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Antikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilkka","family":"Soininen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Laatikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko","family":"Tuomilehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mangialasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiia","family":"Ngandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"1354_CR1","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 37:2315\u20132381. https:\/\/doi.org\/10.1093\/eurheartj\/ehw106","journal-title":"Eur Heart J"},{"key":"1354_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2217\/dmt.12.34","volume":"2","author":"M Bergman","year":"2012","unstructured":"Bergman M, Buysschaert M, Schwarz PE, Albright A, Narayan KV, Yach D (2012) Diabetes prevention: global health policy and perspectives from the ground. Diabetes Manag (Lond) 2:309\u2013321","journal-title":"Diabetes Manag (Lond)"},{"key":"1354_CR3","unstructured":"OECD (2016) Focus on Health Spending. Expenditure by disease, age and gender. OECD"},{"key":"1354_CR4","unstructured":"World Heart Federation (2023) Confronting the world\u2019s number one killer. World Heart Report 2023. World Heart Federation, Geneva"},{"key":"1354_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S et al (2024) Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet 404:572\u2013628. https:\/\/doi.org\/10.1016\/S0140-6736(24)01296-0","journal-title":"The Lancet"},{"key":"1354_CR6","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/ajh\/hpy148","volume":"31","author":"LA Ramirez","year":"2018","unstructured":"Ramirez LA, Sullivan JC (2018) Sex differences in hypertension: where we have been and where we are going. Am J Hypertens 31:1247\u20131254. https:\/\/doi.org\/10.1093\/ajh\/hpy148","journal-title":"Am J Hypertens"},{"key":"1354_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamainternmed.2017.6015","volume":"178","author":"M Brunstr\u00f6m","year":"2018","unstructured":"Brunstr\u00f6m M, Carlberg B (2018) Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels. JAMA Intern Med 178:28\u201336. https:\/\/doi.org\/10.1001\/jamainternmed.2017.6015","journal-title":"JAMA Intern Med"},{"key":"1354_CR8","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al (2018) 2018 ESC\/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 39:3021\u20133104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"},{"key":"1354_CR9","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Lev\u00e4lahti E, Ahtiluoto S, Antikainen R et al (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. The Lancet 385:2255\u20132263. https:\/\/doi.org\/10.1016\/S0140-6736(15)60461-5","journal-title":"The Lancet"},{"key":"1354_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jamda.2017.09.020","volume":"19","author":"A Marengoni","year":"2018","unstructured":"Marengoni A, Rizzuto D, Fratiglioni L, Antikainen R, Laatikainen T, Lehtisalo J et al (2018) The effect of a 2-year intervention consisting of diet, physical exercise, cognitive training, and monitoring of vascular risk on chronic morbidity\u2014the FINGER randomized controlled trial. J Am Med Dir Assoc 19:355-360.e1. https:\/\/doi.org\/10.1016\/j.jamda.2017.09.020","journal-title":"J Am Med Dir Assoc"},{"key":"1354_CR11","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1093\/eurheartj\/ehab922","volume":"43","author":"J Lehtisalo","year":"2022","unstructured":"Lehtisalo J, Rusanen M, Solomon A, Antikainen R, Laatikainen T, Peltonen M et al (2022) Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial. Eur Heart J 43:2054\u20132061. https:\/\/doi.org\/10.1093\/eurheartj\/ehab922","journal-title":"Eur Heart J"},{"key":"1354_CR12","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/jgs.15837","volume":"67","author":"J Kulmala","year":"2019","unstructured":"Kulmala J, Ngandu T, Havulinna S, Lev\u00e4lahti E, Lehtisalo J, Solomon A et al (2019) The effect of multidomain lifestyle intervention on daily functioning in older people. J Am Geriatr Soc 67:1138\u20131144. https:\/\/doi.org\/10.1111\/jgs.15837","journal-title":"J Am Geriatr Soc"},{"key":"1354_CR13","doi-asserted-by":"publisher","first-page":"afae249","DOI":"10.1093\/ageing\/afae249","volume":"53","author":"M S\u00e4\u00e4skilahti","year":"2024","unstructured":"S\u00e4\u00e4skilahti M, Kulmala J, Nurhonen M, Lehtisalo J, Peltonen M, Mangialasche F et al (2024) The effect of multidomain lifestyle intervention on health care service use and costs\u2014secondary analyses from the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): a randomised controlled trial. Age Ageing 53:afae249. https:\/\/doi.org\/10.1093\/ageing\/afae249","journal-title":"Age Ageing"},{"key":"1354_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393\u2013403. https:\/\/doi.org\/10.1056\/NEJMoa012512","journal-title":"N Engl J Med"},{"key":"1354_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019769","volume":"99","author":"F Unda Villafuerte","year":"2020","unstructured":"Unda Villafuerte F, Llobera C\u00e0naves J, Lorente Montalvo P, Moreno Sancho ML, Oliver Oliver B, Bassante Flores P et al (2020) Effectiveness of a multifactorial intervention, consisting of self-management of antihypertensive medication, self-measurement of blood pressure, hypocaloric and low sodium diet, and physical exercise, in patients with uncontrolled hypertension taking 2 or more antihypertensive drugs. Medicine (Baltimore) 99:e19769. https:\/\/doi.org\/10.1097\/MD.0000000000019769","journal-title":"Medicine (Baltimore)"},{"key":"1354_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejcnurse.2010.10.005","volume":"11","author":"A Blokstra","year":"2012","unstructured":"Blokstra A, van Dis I, Verschuren WM (2012) Efficacy of multifactorial lifestyle interventions in patients with established cardiovascular diseases and high risk groups. Eur J Cardiovasc Nurs 11:97\u2013104. https:\/\/doi.org\/10.1016\/j.ejcnurse.2010.10.005","journal-title":"Eur J Cardiovasc Nurs"},{"key":"1354_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstr\u00f6m J, Eriksson JG, Valle TT, H\u00e4m\u00e4l\u00e4inen H, Ilanne-Parikka P et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343\u20131350. https:\/\/doi.org\/10.1056\/NEJM200105033441801","journal-title":"N Engl J Med"},{"key":"1354_CR18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","volume":"9","author":"M Kivipelto","year":"2013","unstructured":"Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R et al (2013) The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement 9:657\u2013665. https:\/\/doi.org\/10.1016\/j.jalz.2012.09.012","journal-title":"Alzheimers Dement"},{"key":"1354_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.puhe.2021.09.006","volume":"200","author":"S Soltani","year":"2021","unstructured":"Soltani S, Saraf-Bank S, Basirat R, Salehi-Abargouei A, Mohammadifard N, Sadeghi M et al (2021) Community-based cardiovascular disease prevention programmes and cardiovascular risk factors: a systematic review and meta-analysis. Public Health 200:59\u201370. https:\/\/doi.org\/10.1016\/j.puhe.2021.09.006","journal-title":"Public Health"},{"key":"1354_CR20","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.2337\/dc18-2475","volume":"42","author":"FJ Basterra-Gortari","year":"2019","unstructured":"Basterra-Gortari FJ, Ruiz-Canela M, Mart\u00ednez-Gonz\u00e1lez MA, Babio N, Sorl\u00ed JV, Fito M et al (2019) Effects of a mediterranean eating plan on the need for glucose-lowering medications in participants with type 2 diabetes: a subgroup analysis of the PREDIMED trial. Diabetes Care 42:1390\u20131397. https:\/\/doi.org\/10.2337\/dc18-2475","journal-title":"Diabetes Care"},{"key":"1354_CR21","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.2337\/dc14-0093","volume":"37","author":"MA Espeland","year":"2014","unstructured":"Espeland MA, Glick HA, Bertoni A, Brancati FL, Bray GA, Clark JM et al (2014) Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care 37:2548\u20132556. https:\/\/doi.org\/10.2337\/dc14-0093","journal-title":"Diabetes Care"},{"key":"1354_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jama.2017.10169","volume":"318","author":"MY Johansen","year":"2017","unstructured":"Johansen MY, MacDonald CS, Hansen KB, Karstoft K, Christensen R, Pedersen M et al (2017) Effect of an intensive lifestyle intervention on glycemic control in patients with type 2 diabetes. JAMA 318:637\u2013646. https:\/\/doi.org\/10.1001\/jama.2017.10169","journal-title":"JAMA"},{"key":"1354_CR23","doi-asserted-by":"publisher","unstructured":"Kranz R-M, Kettler C, Anand C, Koeder C, Husain S, Schoch N, et al (2023) Effect of a controlled lifestyle intervention on medication use and costs: the healthy lifestyle community program (cohort 2). Nutr Health 02601060231164665. https:\/\/doi.org\/10.1177\/02601060231164665","DOI":"10.1177\/02601060231164665"},{"key":"1354_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.archger.2015.11.010","volume":"63","author":"\u00c5G Craftman","year":"2016","unstructured":"Craftman \u00c5G, Johnell K, Fastbom J, Westerbotn M, von Strauss E (2016) Time trends in 20 years of medication use in older adults: findings from three elderly cohorts in Stockholm. Sweden Arch Gerontol Geriatrics 63:28\u201335. https:\/\/doi.org\/10.1016\/j.archger.2015.11.010","journal-title":"Sweden Arch Gerontol Geriatrics"},{"key":"1354_CR25","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.3390\/ijerph20054491","volume":"20","author":"B Safieddine","year":"2023","unstructured":"Safieddine B, Trachte F, Sperlich S, Epping J, Lange K, Geyer S (2023) Trends of antidiabetic and cardiovascular diseases medication prescriptions in type 2 diabetes between 2005 and 2017\u2014a German longitudinal study based on claims data. Int J Environ Res Public Health 20:4491. https:\/\/doi.org\/10.3390\/ijerph20054491","journal-title":"Int J Environ Res Public Health"},{"key":"1354_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","volume":"5","author":"M Kivipelto","year":"2006","unstructured":"Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 5:735\u2013741. https:\/\/doi.org\/10.1016\/S1474-4422(06)70537-3","journal-title":"Lancet Neurol"},{"key":"1354_CR27","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.3390\/ijerph110909345","volume":"11","author":"T Ngandu","year":"2014","unstructured":"Ngandu T, Lehtisalo J, Lev\u00e4lahti E, Laatikainen T, Lindstr\u00f6m J, Peltonen M et al (2014) Recruitment and baseline characteristics of participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)-a randomized controlled lifestyle trial. Int J Environ Res Public Health 11:9345\u20139360. https:\/\/doi.org\/10.3390\/ijerph110909345","journal-title":"Int J Environ Res Public Health"},{"key":"1354_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, S\u00f8rensen HT (2010) The nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106:86\u201394. https:\/\/doi.org\/10.1111\/j.1742-7843.2009.00494.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1354_CR29","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1111\/bcp.14462","volume":"86","author":"A Strampelli","year":"2020","unstructured":"Strampelli A, Cerreta F, Vu\u010di\u0107 K (2020) Medication use among older people in Europe: implications for regulatory assessment and co-prescription of new medicines. Br J Clin Pharmacol 86:1912\u20131920. https:\/\/doi.org\/10.1111\/bcp.14462","journal-title":"Br J Clin Pharmacol"},{"key":"1354_CR30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/1403494817744101","volume":"48","author":"A Lagerin","year":"2020","unstructured":"Lagerin A, T\u00f6rnkvist L, Nilsson G, Johnell K, Fastbom J (2020) Extent and quality of drug use in community-dwelling people aged \u226575 years: a Swedish nationwide register-based study. Scand J Public Health 48:308\u2013315. https:\/\/doi.org\/10.1177\/1403494817744101","journal-title":"Scand J Public Health"},{"key":"1354_CR31","unstructured":"Hales CM, Kohen D (2019) Prescription drug use among adults aged 40\u201379 in the United States and Canada"},{"key":"1354_CR32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00228-019-02669-2","volume":"75","author":"LD Christensen","year":"2019","unstructured":"Christensen LD, Reilev M, Juul-Larsen HG, J\u00f8rgensen LM, Kaae S, Andersen O et al (2019) Use of prescription drugs in the older adult population\u2014a nationwide pharmacoepidemiological study. Eur J Clin Pharmacol 75:1125\u20131133. https:\/\/doi.org\/10.1007\/s00228-019-02669-2","journal-title":"Eur J Clin Pharmacol"},{"key":"1354_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5881","volume":"33","author":"N Wabe","year":"2024","unstructured":"Wabe N, Timothy A, Urwin R, Xu Y, Nguyen A, Westbrook JI (2024) Analysis of longitudinal patterns and predictors of medicine use in residential aged care using group-based trajectory modeling: the \u201cMEDTRAC-Cardiovascular\u201d Longitudinal Cohort Study. Pharmacoepidemiol Drug Saf 33:e5881. https:\/\/doi.org\/10.1002\/pds.5881","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1354_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.608136","author":"L Cong","year":"2020","unstructured":"Cong L, Ren Y, Hou T, Han X, Dong Y, Wang Y et al (2020) Use of cardiovascular drugs for primary and secondary prevention of cardiovascular disease among rural-dwelling older Chinese adults. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.608136","journal-title":"Front Pharmacol"},{"key":"1354_CR35","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.14283\/jpad.2024.105","volume":"11","author":"S Son","year":"2024","unstructured":"Son S, Speechley M, Zou GY, Kivipelto M, Mangialasche F, Feldman HH et al (2024) Potentially modifiable dementia risk factors in Canada: an analysis of Canadian longitudinal study on aging with a multi-country comparison. J Prev Alzheimers Dis 11:1490\u20131499. https:\/\/doi.org\/10.14283\/jpad.2024.105","journal-title":"J Prev Alzheimers Dis"},{"key":"1354_CR36","doi-asserted-by":"publisher","first-page":"e1600","DOI":"10.1016\/S2214-109X(24)00275-4","volume":"12","author":"RS Paradela","year":"2024","unstructured":"Paradela RS, Calandri I, Castro NP, Garat E, Delgado C, Crivelli L et al (2024) Population attributable fractions for risk factors for dementia in seven Latin American countries: an analysis using cross-sectional survey data. Lancet Glob Health 12:e1600\u2013e1610. https:\/\/doi.org\/10.1016\/S2214-109X(24)00275-4","journal-title":"Lancet Glob Health"},{"key":"1354_CR37","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1097\/HJH.0b013e328330b6bf","volume":"27","author":"TL Ahola","year":"2009","unstructured":"Ahola TL, Jula AM, Kantola IM, M\u00e4ki J, Klaukka T, Reunanen A (2009) Positive change in the utilization of antihypertensive and lipid-lowering drugs among adult diabetics in Finland. Results from large national database between 2000 and 2006. J Hypertension 27:2283. https:\/\/doi.org\/10.1097\/HJH.0b013e328330b6bf","journal-title":"J Hypertension"},{"key":"1354_CR38","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.53562","volume":"6","author":"PK Chehal","year":"2023","unstructured":"Chehal PK, Uppal TS, Turbow S, Fernandes G, Haw JS, Shah MK et al (2023) Continuity of medication use by US adults with diabetes, 2005\u20132019. JAMA Netw Open 6:e2253562. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.53562","journal-title":"JAMA Netw Open"},{"key":"1354_CR39","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12877-022-03144-x","volume":"22","author":"B Ali Babar","year":"2022","unstructured":"Ali Babar B, Vu M, Koponen M, Taipale H, Tanskanen A, Kettunen R et al (2022) Prevalence of oral anticoagulant use among people with and without Alzheimer\u2019s disease. BMC Geriatr 22:464. https:\/\/doi.org\/10.1186\/s12877-022-03144-x","journal-title":"BMC Geriatr"},{"key":"1354_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-025-01160-9","author":"TE Strandberg","year":"2025","unstructured":"Strandberg TE, Benetos A (2025) Hippocratic considerations about statin treatment for patients over 75 years of age. Eur Geriatr Med. https:\/\/doi.org\/10.1007\/s41999-025-01160-9","journal-title":"Eur Geriatr Med"},{"key":"1354_CR41","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00228-022-03320-3","volume":"78","author":"M Vu","year":"2022","unstructured":"Vu M, Kettunen R, Tolppanen A-M, Hartikainen S, Taipale H (2022) Statin discontinuation in persons with and without Alzheimer\u2019s disease. Eur J Clin Pharmacol 78:1145\u20131153. https:\/\/doi.org\/10.1007\/s00228-022-03320-3","journal-title":"Eur J Clin Pharmacol"},{"key":"1354_CR42","doi-asserted-by":"publisher","first-page":"2110675","DOI":"10.1080\/22423982.2022.2110675","volume":"81","author":"MH Nielsen","year":"2022","unstructured":"Nielsen MH, Backe MB, Pedersen ML (2022) Prevalence of patients using antihypertensive medication in Greenland, and an assessment of the importance of diagnosis for the associated quality of care\u2014a cross-sectional study. Int J Circumpolar Health 81:2110675. https:\/\/doi.org\/10.1080\/22423982.2022.2110675","journal-title":"Int J Circumpolar Health"},{"key":"1354_CR43","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12877-025-05979-6","volume":"25","author":"J Lehtisalo","year":"2025","unstructured":"Lehtisalo J, S\u00e4\u00e4skilahti M, H\u00e4rk\u00e4nen T, Kulmala J, Hemi\u00f6 K, Siltanen S et al (2025) Changes in older persons\u2019 lifestyle and perceived health over time and during the COVID-19 pandemic: findings from the extended follow-up of the FINGER randomized controlled trial from 2009 to 2020. BMC Geriatr 25:308. https:\/\/doi.org\/10.1186\/s12877-025-05979-6","journal-title":"BMC Geriatr"},{"key":"1354_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.621417","author":"S Chiuve","year":"2006","unstructured":"Chiuve S, McCullough M, Sacks F, Rimm E (2006) Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.621417","journal-title":"Circulation"},{"key":"1354_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1373\/clinchem.2018.288332","volume":"65","author":"EM Crimmins","year":"2019","unstructured":"Crimmins EM, Shim H, Zhang YS, Kim JK (2019) Differences between men and women in mortality and the health dimensions of the morbidity process. Clin Chem 65:135\u2013145. https:\/\/doi.org\/10.1373\/clinchem.2018.288332","journal-title":"Clin Chem"},{"key":"1354_CR46","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","volume":"314","author":"ED Kantor","year":"2015","unstructured":"Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL (2015) Trends in prescription drug use among adults in the United States from 1999\u20132012. JAMA 314:1818\u20131831. https:\/\/doi.org\/10.1001\/jama.2015.13766","journal-title":"JAMA"},{"key":"1354_CR47","unstructured":"Koskinen S, Lundqvist A, Ristiluoma N (2012) Health, functional capacity and welfare in FInland in 2011. National Institute for Health and Welfare (THL), Helsinki"}],"updated-by":[{"DOI":"10.1007\/s41999-025-01397-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000}}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-025-01354-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:01:57Z","timestamp":1777017717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-025-01354-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1354"],"URL":"https:\/\/doi.org\/10.1007\/s41999-025-01354-1","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s41999-025-01397-4","URL":"https:\/\/doi.org\/10.1007\/s41999-025-01397-4","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JT owns shares in Orion Pharma. The other authors have no relevant financial or non-financial interests to disclose. On behalf of all other authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The participants gave written informed consent before enrolment in the study including also consent for linking national register data to the clinical trial data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The FINGER study was approved by the coordinating ethics committee of the Hospital District of Helsinki and Uusimaa (HUS\/1204\/2017).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}